PRODUCT SHOWCASE

VanishPoint®

VanishPoint® syringes are available in a variety of sizes, needle gauges, and needle lengths. The needle is automatically retracted directly from the patient into the barrel of the syringe when the plunger handle is fully depressed. The pre-removal, automated retraction virtually eliminates exposure to the contaminated needle, effectively reducing the risk of needlestick injury.

Brochures

VanishPoint Brochure
PDF File

Your Safety Is Our Top Priority 
We make safety safe

PDF File

Studies

Reducing Needlestick Injuries from Active Safety Devices: A Passive Safety-Engineered Device Trial

Goris, A. J., Glotzer, J., Gemeinhart, N. W., Wojtak, L. M., Zirges, C. C., & Babcock, H. (2013). Reducing needlestick injuries from active safety devices: a passive safety-engineered device trial. American Journal of Infection Control41(6), S80.

Eliminating Needlesticks: CREATING A SAFER ENVIRONMENT FOR BOTH PATIENT AND CAREGIVER

By Gail J. Callas, BSN, RN, MS

A New Approach to the Design of Retractable Needle Technology

By Richard P. Meyst, BSME, MSME

The Effectiveness of Low Dead Space Syringes for Reducing the Risk of Hepatitis C Virus Acquisition Among People Who Inject Drugs: Findings From a National Survey in England, Wales, and Northern Ireland

By Adam Trickey, 1, Sara Croxford, 2 Eva Emanuel, 2 Samreen Ijaz, 2 Matthew Hickman, 1,3 Joanna Kesten, 1,3,4 Clare Thomas, 1,3,4 Claire Edmundson, 2 Monica Desai, 2 and Peter Vickerman1,3

Sharps Safety Case Studies: Correctional Health Program Needlestick Safety Study

By Candice McLamb, BSN, RN

Needlestick Injury Rates According to Different Types of Safety – Engineered Devices: Results of a French Multicenter Study

By William Tosini, MD; Ce´line Ciotti, RN; Floriane Goyer, RN; Isabelle Lolom, MSc; Franc¸ois L’He´riteau, MD; Dominique Abiteboul, MD; Gerard Pellissier, PhD; Elisabeth Bouvet, MD

Community Pharmacy Distribution of Naloxone

College of Pharmacists of BC
BC Centre for Disease Control – Harm Reduction Program
Sponsored in part by the BC Ministry of Health

Survival of Hepatitis C Virus in Syringes: Implication for Transmission among Injection Drug Users

Paintsil, E., He, H., Peters, C., Lindenbach, B. D., & Heimer, R. (2010). Survival of hepatitis C virus in syringes: implication for transmission among injection drug users. The Journal of infectious diseases202(7), 984-990.

Raphael Dubé

President

Contact Raphael Dubé

Please feel free to contact Raphael Dubé directly by phone at:
(705) 328-2518
or by email clicking the button below.

CardioMed Supplies Inc.

199 St. David Street
Lindsay, ON, Canada
K9V-5K7
Phone: (705) 328-2518
Fax: (705) 328-9747
Toll-Free: 1-800-387-9757
Email: [email protected]

Nipro Canada

199 St. David Street
Lindsay, ON, Canada
K9V-5K7

Phone: (705) 328-2518
Fax: (705) 328-9747
Toll-Free: 1-800-387-9757
Email: [email protected]